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Abstract
Centromeres are specialized chromosome domains that control chromosome segregation during mitosis, but little is known
about the mechanisms underlying the maintenance of their integrity. Centromeric ultrafine anaphase bridges are
physiological DNA structures thought to contain unresolved DNA catenations between the centromeres separating during
anaphase. BLM and PICH helicases colocalize at these ultrafine anaphase bridges and promote their resolution. As PICH is
detectable at centromeres from prometaphase onwards, we hypothesized that BLM might also be located at centromeres
and that the two proteins might cooperate to resolve DNA catenations before the onset of anaphase. Using
immunofluorescence analyses, we demonstrated the recruitment of BLM to centromeres from G2 phase to mitosis. With
a combination of fluorescence in situ hybridization, electron microscopy, RNA interference, chromosome spreads and
chromatin immunoprecipitation, we showed that both BLM-deficient and PICH-deficient prometaphase cells displayed
changes in centromere structure. These cells also had a higher frequency of centromeric non disjunction in the absence of
cohesin, suggesting the persistence of catenations. Both proteins were required for the correct recruitment to the
centromere of active topoisomerase IIa, an enzyme specialized in the catenation/decatenation process. These observations
reveal the existence of a functional relationship between BLM, PICH and topoisomerase IIa in the centromere decatenation
process. They indicate that the higher frequency of centromeric ultrafine anaphase bridges in BLM-deficient cells and in cells
treated with topoisomerase IIa inhibitors is probably due not only to unresolved physiological ultrafine anaphase bridges,
but also to newly formed ultrafine anaphase bridges. We suggest that BLM and PICH cooperate in rendering centromeric
catenates accessible to topoisomerase IIa, thereby facilitating correct centromere disjunction and preventing the formation
of supernumerary centromeric ultrafine anaphase bridges.
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Introduction
The centromere is a highly differentiated chromosomal
structure consisting, in human cells, of a-satellite DNA repeats
[1]. It plays an essential role in cell division, particularly in
kinetochore assembly, and in ensuring the segregation of equal
number of chromosomes to daughter cells during mitosis [2]. The
maintenance of centromere stability is thus essential to prevent
chromosomal instability and cancer development [3]. Our interest
in centromere stability began with the unexpected discovery that a
helicase-like protein, PICH (Plk1-interacting checkpoint ‘‘heli-
case’’) and the Bloom syndrome helicase (BLM) colocalized to
centromeric ultrathin DNA threads that could not be counter-
stained with conventional DNA dyes or antibodies against histones
[4,5]. These threads were found to be common in all cultured
normal cells tested, and are therefore probably physiological
structures. These PICH- and BLM-positive DNA threads, which
are also called ultrafine anaphase bridges (UFBs), are thought to
contain unresolved DNA catenations between the centromeres
separating during anaphase or to originate from incompletely
replicated DNA [4,5]. Almost all the UFBs detected in untreated
cells are of centromeric origin and have been proposed to prevent
reactivation of the spindle assembly checkpoint (SAC) during early
anaphase, by maintaining tension across centromeres [4,6]. As
cells progress through anaphase, UFBs become progressively
longer and decrease in number. They are no longer detectable by
telophase. The resolution of centromeric UFBs requires topo-
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Figure 1. GFP-BLM localizes to centromeres in G2/prophase cells. (A) Localization of GFP-BLM (green) to centromeres in late G2 cells. Nuclei
were visualized by DAPI staining (blue). G2 cells were stained with antibodies against cyclin B1. Cells were stained with CREST serum to visualize
centromeres (red). Lower panels are the magnification of the corresponding upper panels. Scale bar = 5 mm. (B) Two hundred cells with GFP-BLM-
positive centromeres were analyzed by staining for cyclin B1 (cyclin B- or cyclin B+). The percentage of cells in each category is indicated (left panel),
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isomerase IIa (Topo IIa) activity and occurs after the onset of
anaphase, after the disappearance of cohesin [6,7]. Thus, sister
centromeres are held together through double-stranded DNA
catenations until the end of anaphase, accounting for the strong
induction of centromeric UFBs by catalytic inhibitors of Topo II
[4,5]. The frequency of PICH-positive UFBs is also higher in
BLM-deficient cells than in control cells, suggesting the involve-
ment of BLM in their resolution [5]. This point is of particular
interest because BLM deficiency causes Bloom’s syndrome, an
autosomal recessive disease displaying one of the strongest known
correlations between chromosomal instability and an increase in
the risk of cancer at an early age [8]. The hallmark of BLM-
deficient cells is a high frequency of sister chromatid exchanges
(SCEs) [8]. Thus, BLM plays a crucial role in preventing genetic
instability and cancer. In normal cells, BLM is detected only on
UFBs in anaphase, whereas PICH staining is detected as early as
metaphase [5]. PICH is required for the localization of BLM to
anaphase UFBs, and BLM is required for the chromatin
remodeling function of PICH in vivo, the two proteins cooperating
to limit histone incorporation into UFBs and to promote their
resolution [9]. We hypothesized that the functional relationship
between PICH and BLM might also be of major importance
before anaphase in the maintenance of centromere integrity.
We report here the localization of BLM to the centromere of
chromosomes from G2 phase to mitosis. We show that PICH and
BLM deficiencies are associated with changes in centromere
structure, with an increase in centromeric non disjunction in
cohesin-depleted cells and a defect in the recruitment of active
Topo IIa to centromeres. Our results reveal the existence of a new
centromeric mechanism involving cooperation between PICH and
BLM, likely to render some centromeric catenates accessible to
Topo IIa before anaphase onset, thereby facilitating correct
centromeric disjunction and preventing the formation of super-
numerary UFBs.
Results
BLM is a Centromeric Protein
PICH is a centromeric protein [4]. As BLM, like PICH,
localized with centromeric UFBs [5], we first investigated whether
BLM also localized to centromeres. We analyzed the subcellular
distribution of stably expressed GFP-tagged BLM protein in
asynchronous GM08505 BS cells (GFP-BLM cells) [10]. We
detected GFP-BLM in PML bodies, as expected [11] (Figure S1),
but in some cells, BLM foci were smaller, double-dotted and no
longer colocalized within PML bodies. Using CREST serum as a
centromeric marker, we showed, by cyclin B1 staining [12], that
73% of cells with GFP-BLM-positive centromeres were in G2-
phase or early mitosis (Figure 1A and 1B, left panel). These cells
included a mean of 27 GFP-BLM-positive pairs of centromeres (7
to 59 pairs). By contrast, only 10 GFP-BLM-positive centromeres
(1 to 24 pairs) were detected in late S-phase cells (most
centromeres being paired), negative for cyclin B1 staining
(Figure 1B, right panel). All the centromeres in prophase cells
displayed positive staining for GFP-BLM (Figure 1C). These
results suggest that BLM is progressively loaded to the centromeres
from late S phase until mitosis. We then investigated whether the
helicase and/or DNA binding activities of BLM were required for
centromeric localization, using GM08505 BS cells stably trans-
fected with a construct encoding either the BLM protein with an
inactive helicase domain (GFP-I841T) or with both the helicase
and DNA binding domains inactivated (GFP-G891E) [13]. We
found that DNA-binding activity was required for the centromeric
localization of BLM, whereas helicase activity was not. Indeed,
GFP-G891E displayed a diffuse distribution in BS cells and was
not detectable at centromeres, suggesting that BLM may interact
with centromeric DNA (Figure 1D).
The centromeric localization of endogenous BLM was also
investigated in immunofluorescence experiments with two differ-
ent anti-BLM antibodies, on mitotic chromosome spreads from
HeLa S3 cells at prometaphase/metaphase stage, downregulated
for BLM (siBLM) or without BLM downregulation (siCtrl). In
HeLa siCtrl cells, we detected endogenous BLM at centromeres,
with CREST serum used as a centromeric marker. The siRNA-
mediated depletion of BLM (siBLM) resulted in the absence of the
BLM signal at centromeres, confirming the specificity of the anti-
BLM antibodies (Figure 2A). Closer examination of the centro-
meres of each chromosome showed the BLM signal to be present
on about 84% of centromeres in HeLa siCtrl cells and on 1.7% of
centromeres from HeLa siBLM cells (Figure 2B). Thus, BLM is
clearly a centromeric protein.
BLM and PICH Deficiencies are Associated with Changes
in Centromeric DNA Structure
We investigated the possible effects of BLM deficiency on
centromere structure. We used a FISH (fluorescence in situ
hybridization)-based assay to investigate the centromeric DNA
organization of one chromosome and its volume (chromosome 8,
CEN-8 probe [14]) in GM08505 BLM-deficient cells stably
expressing a GFP vector (BS cells) and in GFP-BLM cells during
prometaphase and metaphase (Figure 3A). We found that CEN-8
signal volume in BS cells was less than half that in control cells,
indicating that BLM is involved in centromeric DNA structure
(Figure 3B, left panel). For confirmation of these findings, we
analyzed the effects of BLM deficiency on the structural
morphology of the centromeric DNA in BS and GFP-BLM
metaphase cells by electron microscopy (EM) (Figure 3C).
Centromeric chromatin was identified adjacent to the typical
kinetochore structure. Immunofluorescence analysis of several
kinetochore/centromere markers confirmed that BLM deficiency
had no major effect on kinetochore structure, as previously shown
for PICH-deficient cells [4] (Figure S2). However, the centromeric
chromatin was clearly more dense in BS cells than in GFP-BLM
cells (Figure 3C), confirming an effect on centromeric DNA
organization of the absence of BLM. We next performed FISH
experiments in GFP-BLM cells downregulated for PICH (siPICH)
or without PICH downregulation (siCtrl). We found that CEN-8
signal volume in PICH-downregulated cells was about half that in
control cells, indicating that PICH is also involved in centromeric
DNA structure before anaphase onset (Figure 3B, right panel).
These results are not the consequence of a coregulation of PICH
and BLM genes, because the deficiency of one protein did not
affect the expression of the other (Figure 4A, lower left panel).
Finally, CEN-8 signal volume in HeLa cells depleted of BLM,
PICH or both proteins was significantly lower than that in control
cells (Figure S3). There was therefore no additive or synergistic
together with the mean number of GFP-BLM-positive centromeres per cell (right panel). Bars indicate the standard deviation (SD). (C) Localization of
GFP-BLM (green) to centromeres (red) in prophase cells. The nucleus and centromeres were visualized as in A. Scale bar = 5 mm. (D) Localization of
GFP-BLM (green) with an inactive helicase domain (GFP-I841T) or with both the helicase and DNA-binding domains inactivated (GFP-G891E). Nuclei
and centromeres were visualized as in A. Scale bar = 5 mm.
doi:10.1371/journal.pone.0033905.g001
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Figure 2. BLM localizes to centromeres in mitotic cells. (A) Endogenous BLM localizes to centromeres in HeLa cells. Wide-field microscopy after
immunofluorescence staining on chromosome spreads obtained by cytocentrifugation of BLM siRNA-transfected or control siRNA-transfected HeLa
S3 cells. Staining is shown for BLM (green), CREST (red) and chromosomes (blue). Single chromosome magnifications are shown (upper panels).
Proteins levels were assessed by immunoblotting, probing the same membrane with anti-BLM (ab-476) antibody and then with anti-b actin antibody,
as a loading control (lower left panel). Quantification of centromeric fluorescence signals for BLM (normalized according to the CREST signal) for a
total of 20 centromeres in control cells (siCtrl) and 24 centromeres in BLM-depleted cells (siBLM) from two independent experiments, demonstrate
the specificity of ab476 BLM antibodies (lower right panel). Data are means and SD normalized with respect to controls. Scale bar = 5 mm. (B)
Centromeres detected with CREST serum (red) from all the chromosomes of HeLa siCtrl cells and HeLa siBLM cells from Figure 2A were analyzed for
BLM signals (green). Chromosomes were visualized by DAPI staining (blue) (left panels). The same analysis was performed on a total of 9 HeLa siCtrl
cells and 9 HeLa siBLM cells from two independent experiments: the percentage of centromeres giving a BLM signal is shown (right panel).
doi:10.1371/journal.pone.0033905.g002
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Figure 3. Structural defects at the centromeres in BLM-and PICH-deficient cells. (A) FISH with the CEN-8 probe (green) on metaphase BS
and GFP-BLM cells. Chromosomes are visualized by DAPI staining (red). Bar = 5 mm. (B) Comparison of the volume of the centromeric FISH signal
detected on chromosomes 8 from GFP-BLM (defined as 1) and BS cells (left panel) and from GFP-BLM cells with (siPICH) and without (siCtrl) PICH
downregulation (defined as 1) (right panel). We analyzed 45 metaphase cells from three independent experiments for each cell line. (C) GFP-BLM cells
(left panel) and BS cells (right panel) were processed for electron microscopy. Scale bar = 1 mm. Inset: schematic diagram of the regions of interest
(white squares) (MT: microtubules, KT: kinetochore outer plate and CC: centromeric chromatin). Eight centromeres from two independent
experiments were analyzed.
doi:10.1371/journal.pone.0033905.g003
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effect of the depletion of BLM and PICH on CEN-8 signal
volume, suggesting that these proteins are involved in the same
regulatory pathway. These results also confirmed the involvment
of BLM and PICH in centromeric DNA structure before anaphase
onset.
BLM and PICH are Required for Complete Centromere
Disjunction
As BLM localizes to centromeres (Figures 1 and 2), we
investigated whether, in addition to its potential role in resolving
UFBs during anaphase [5,15], BLM might be involved in
Figure 4. BLM-deficient cells and PICH-downregulated display non disjunction of centromeres and impaired recruitment of active
Topo IIa to centromeres. (A) GFP-BLM and BS cells were transfected for 72 hours with Rad21 siRNAs and transfected either with control siRNAs or
with PICH siRNAs. BLM, PICH and Rad21 proteins levels were assessed by immunoblotting, probing the same membrane with anti-BLM (ab-476), anti-
PICH and anti-Rad21 antibodies and with anti-b actin antibody, as a loading control (lower left panel). Chromosome spreads were performed and
sorted on the basis of their phenotype: X-shapes, incomplete disjunction or complete disjunction. The scale bars indicate 5 mm (upper left panel). This
classification is based on the intensity profiles of centromeres (upper right panel). We analyzed 500 spreads from three independent experiments for
each cell line. The frequency of each phenotype, in each of the three cell lines, is shown in the histogram (lower right panel). Bars represent SD. (B)
GFP-BLM, BS and GFP-I841T cells were transfected for 72 hours with Rad21 siRNAs and the same experiments as in (A) (right panels) were carried out.
We checked the levels of BLM and Rad21 proteins by western blotting (left panels).
doi:10.1371/journal.pone.0033905.g004
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preventing UFB formation, by contributing to the centromeric
DNA decatenation process before the metaphase-anaphase
transition. DNA catenation induced by the inhibition of Topo
IIa has been shown to maintain sister chromatid cohesion in the
absence of cohesin complexes [7,16]. We thus analyzed chromo-
some spreads from BS cells and from GFP-BLM cells arrested in
prometaphase (+colchicine), with (siPICH) or without (siCtrl)
PICH knockdown (Figure 4A). For these experiments, Rad21, the
cleavable subunit of cohesin, was depleted from all cell lines
(siRad21) (Figure 4A, lower left panel). BLM deficiency and PICH
knockdown were associated with an increase in centromeric
cohesion. Indeed, we observed three distinct and different
phenotypes: classical X-shaped chromosomes probably corre-
sponding to cells not transfected with Rad21 siRNA (X-shapes),
the expected fully disjoined chromatids resulting from cohesin
depletion (complete disjunction), and a third, unusual phenotype
of separated sister chromatids that were still physically linked,
reflecting incomplete chromatid disjunction (incomplete disjunc-
tion) (Figure 4A, upper left panels). Careful examination of these
‘‘separated but still paired’’ chromatids revealed that they were
mostly linked via their centromeres (visualized as the major
chromosomal constriction). This observation was confirmed by
quantifying the intensity profiles of the centromeric region
between the two chromatids of the ‘‘X-shape’’ and ‘‘incomplete
disjunction’’ phenotypes (Figure 4A, upper right panel). We
determined the frequency of each phenotype in the four cell lines
and found that about 15% of the prometaphase cells presented the
X-shaped phenotype. About 19% of siRad21-treated BS cells,
siRad21+siPICH treated GFP-BLM cells, and siRad21+siPICH-
treated BS cells presented completely disjoined chromatids,
whereas about 66% of these cells, displayed an incomplete
centromere disjunction phenotype (Figure 4A, lower right panel).
By contrast, in GFP-BLM cells with Rad21 knockdown only,
34.2% of the cells displayed complete sister chromatid disjunction
and 50.5% had separated sister centromeres that remained paired
(as opposed to the 66% observed in the other cell lines). Similar
results were obtained in Rad21-depleted HeLa cells, with a
significantly higher frequency of cells presenting an ‘‘incomplete
disjunction’’ phenotype and a significantly lower frequency of cells
presenting a ‘‘complete disjunction’’ phenotype in cells depleted of
BLM or PICH (Figure S4). Rad21 levels were initially similar in
GFP-BLM cells and in HeLa cells and siRNA-mediated Rad21
downregulation was similarly effective in all cell lines. The
differences in the percentage of cells with an incomplete
disjunction phenotype therefore did not reflect differences in the
efficacy of siRNA-mediated Rad21 downregulation (Figure S5).
Finally, we performed the same chromosome spread analysis with
GFP-BLM-I841T cells (inactive helicase domain), comparing the
results with those for BS and GFP-BLM cells. Similar results were
obtained with both Rad21-depleted GFP-BLM-I841T cells and
Rad21-depleted BS cells, (Fig. 4B right panel), despite GFP-BLM-
I841T and GFP-BLM cells having similar amounts of BLM
protein (Figure 4B, left panel).
Together, these results show that both BLM and PICH are
involved in the complete disjunction of sister centromeres
independently of the cohesin pathway, strongly suggesting that
in the absence of BLM and/or PICH, some centromeric
catenations are not processed, leading to an increase in
centromeric non disjunction. The results for cells expressing
BLM with an inactive helicase domain indicate that the helicase
activity of BLM is involved in the complete disjunction of sister
centromeres.
Lastly, we observed no additive or synergistic effect of PICH
and BLM deficiencies on the ‘‘incomplete disjunction’’ phenotype,
suggesting that these two proteins are involved in the same
regulatory pathway.
Centromeric UFBs are not Detectable in PICH-depleted
Cells
The findings reported above suggest that the higher frequency
of centromeric UFBs in BLM-deficient cells [5], which we also
confirmed, may be due to a lack of BLM processing activity of
some centromeric DNA catenations. These results also suggest
that the centromeric DNA catenations persisting in PICH-
deficient cells probably result in an increase in centromere UFB
frequency. We investigated the effect of PICH knockdown on the
frequency of UFBs, by monitoring BLM. We found that PICH
depletion resulted in a three-fold decrease in the number of cells
presenting UFBs and in a five-fold decrease in the number of
BLM-positive UFBs (Figure S6A and S6B). However, most of the
BLM-positive UFBs detected were also positive for PICH staining,
indicating that PICH downregulation was incomplete, with UFBs
positive for both BLM and PICH probably forming in cells not
efficiently transfected with PICH siRNA. Only a minor fraction of
UFBs (5–6%) were positive for BLM staining and negative for
PICH staining and the frequency of these UFBs was not affected
by PICH downregulation (Figure S6B). The lack of detection of an
increase in the frequency of BLM-positive UFBs in PICH-depleted
anaphase cells can be accounted for by recent observations
showing that PICH is required for BLM localization to anaphase
threads [15]. Nevertheless, we cannot exclude the possibility that
UFBs may be prematurely disrupted in the absence of PICH, as
previously suggested [4], or that they may not form at all. We were
unable to visualize UFBs in the absence of PICH, even by BrdU
staining, probably due to the inherent limitations of this method
[17]. However, as PICH downregulation is associated with an
increase in the frequency of cells presenting an ‘‘incomplete
disjunction’’ phenotype, UFB frequency is probably higher in
these cells, although these structures are not detectable in the
absence of PICH.
BLM and PICH are Required for the Recruitment of Topo
IIa to Centromeres
Topo IIa is known to be responsible for the elimination of
centromeric DNA catenation [16]. We investigated the possible
role of BLM and PICH in centromeric decatenation, by assessing
the recruitment of active Topo IIa to the pericentromeric region
(satellite 3) and to the centromere of chromosomes X (a-satellite
sequences DXZ1) and 17 (D17Z1). Topo IIa was trapped on DNA
by 15 minutes of treatment with etoposide [18], and analyzed by
chromatin immunoprecipitation (ChIP) coupled to semi-quantita-
tive PCR (see Methods) in BS cells and GFP-BLM cells (Figure 5A)
and in PICH-depleted GFP-BLM cells (siPICH) and their control
cells (siCtrl) (Figure 5B). Immunoprecipitation of active Topo IIa
in BS cells, PICH-depleted GFP-BLM cells and their respective
control cells resulted in similar amplification of satellite 3
(Figure 5A and 5B, lower panels). We then used this as a control
for normalization and found that the amounts of DXZ1 and
D17Z1 amplified sequences were four and two times higher,
respectively, in GFP-BLM control cells than in BS cells (Figure 5A,
upper panel). DXZ1 and D17Z1 sequences bound to active Topo
IIa were also twice as abundant in control cells as in PICH-
depleted cells (Figure 5B, upper panel), whereas the total amount
of Topo IIa was similar in all conditions (Figure 5C). We
performed the same analysis with GFP-I841T cells, comparing the
results obtained with those for BS and GFP-BLM cells, and
obtained similar results for GFP-I841T cells and BS cells
BLM and PICH in Centromere Disjunction
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(Figure 5D). Thus, active Topo IIa is significantly less abundant at
the centromeres of BLM-deficient cells and PICH-deficient cells
than at those of control cells. These results also indicate that the
helicase activity of BLM is involved in the recruitment of active
Topo IIa to centromeres.
Discussion
We report here a new localization and function for BLM at
centromeres. We also report that BLM cooperates with PICH at
centromeres, and that both these proteins play an important role
in a previously unknown mechanism involving the recruitment of
active Topo IIa to centromeres to eliminate DNA catenation
before the onset of anaphase.
Our FISH experiments and EM images showed changes in the
structure of centromeric chromatin in the absence of BLM or
PICH (Figure 3). Recombinant PICH has recently been shown to
have nucleosome remodeling activity in vitro, and BLM has been
shown to be required for the chromatin remodeling function of
PICH during anaphase in vivo [15]. On the other hand, changes in
DNA topology are required for efficient mitotic decatenation by
Top2, the fission yeast homolog of Topo IIa [19]. We therefore
propose a model in which the combined action of BLM and PICH
promotes the organization of centromeric chromatin, thereby
rendering some centromeric catenates accessible to Topo IIa
(Figure 6). This pathway may allow the Topo IIa-mediated
resolution of some centromeric DNA catenations as soon as the
cells enter prometaphase, thereby preventing centromeric non
disjunction and the potential formation of additional UFBs that
might interfere with abscission [7].
Our results also indicate that, in addition to their role in
resolving physiological UFBs [5,15], BLM and PICH may
participate in the prevention of UFB formation. Thus, the
additional centromeric UFBs that form in BLM-deficient cells or
in cells treated with inhibitors of the catalytic activity of Topo IIa
may include both newly formed UFBs and unresolved physiolog-
ical UFBs: these UFBs are probably similar in nature but of
different origins. Indeed, cohesin complexes preserve catenation at
centromeres until the onset of anaphase, accounting for the
presence of physiological UFBs [7]. The resolution of centromeric
catenation therefore depends on cohesin removal [7]. However,
our results indicate that some centromeric catenations are
processed before the onset of anaphase to prevent the formation
of additional UFBs. Thus, physiological UFBs may arise from
catenations locally protected by cohesin complexes and processed
at anaphase onset, whereas additional UFBs may arise from
catenations not resolved at an earlier step.
In conclusion, the new centromeric decatenation mechanism
reported here is probably the first step in a two-step centromeric
decatenation process dependent on the coordinated action of
BLM, PICH and Topo IIa. Moreover, our studies shed light on
the mechanisms underlying the genetic instability and predispo-
sition to cancer associated with Bloom’s syndrome.
Materials and Methods
Cell Lines, Cell Culture and Transfections
The GFP-BLM construct was kindly provided by Nathan Ellis.
The SV40-transformed fibroblast cell line GM08505B, derived
from the BS patient 42 (RaFr) of the Bloom’s syndrome registry,
was obtained from the NIGMS Human Genetic Mutant Cell
Repository (Camden, NJ, USA). BS and GFP-BLM cells were
obtained by transfecting BS GM08505B cells with the EGFP-C1
vector alone (Clontech, Mountain View, CA), or with the same
vector containing the full-length BLM cDNA [20], respectively, in
the presence of JetPEI reagent (Ozyme). GFP-I841T cells were
obtained by transfecting BS GM08505B cells as described above,
with the EGFP-C1 vector containing the full-length BLM cDNA
mutated at codon 841 (see site-directed mutagenesis).
HeLa and HeLa S3 cells, obtained from the American Tissue
Culture Collection.
HeLaV cells and HeLashBLM cells were obtained by trans-
fecting cells with an empty pSM2 vector or with the same vector
encoding a short hairpin RNA sequence directed against BLM
(Open Biosystems, clone V2HS-89234), respectively, with JetPEI
reagent. After 48 h, selection with 1 to 5 mg/ml puromycin
(Invivogen) was applied. Individual colonies were isolated and
cultured in medium containing 0.5 mg/ml puromycin [10,21].
All cell lines were cultured in DMEM (Gibco) supplemented
with 10% decomplemented FCS (Invitrogen), L-glutamine and
antibiotics.
Cells were transfected with siRNAs directed against BLM
(48 h), PICH (72 h) and Rad21 (72 h) (ON-TARGETplus,
SMARTpool, Dharmacon) and with a control non-targeting pool
of siRNA (ON-TARGETplus siCONTROL Non Targeting Pool,
Dharmacon) (100 nM final concentration) in the presence of
Dharmafect 1 (Dharmacon) according to the manufacturer’s
instructions. The sequences of all siRNA oligonucleotides used are
presented in Table S1. The pool of siRNAs targeting PICH has
been shown to have no effect on nocodazole-induced SAC (spindle
assembly checkpoint) activation [22].
Chemicals
Etoposide (Sigma) was used at a final concentration of 0.5 mM.
Plasmid Construction and Site-directed Mutagenesis
Site-directed mutagenesis was performed with the EGFP-C1
vector containing the full-length BLM cDNA: Ile-841 and Gly-891
were mutated with the QuikChange XL site-directed mutagenesis
kit (Agilent) according to the manufacturer’s instructions.
Primer 1 (59-CCCAGGGTACAGAAGGACACCCTGACT-
CAGCTGAAG - 39) and primer 2 (59-CTTCAGCTGAGT-
CAGGGTGTCCTTCTGTACCCTGGG- 39) were used to
mutate Ile-841 and primer 3 (59-GCACCACCCATATGATT-
CAGAGATAATTTACTGCCT- 39) and primer 4 (59-AGG-
CAGTAAATTATCTCTGAATCATATGGGTGGTG- 39) were
used to mutate Gly-891.
Western-blot Analysis
Cells were lysed in 8 M urea buffer (8 M urea, 150 mM b-
mercaptoethanol, and 50 mM Tris (pH 7.4) in water), sonicated
and heated. Samples equivalent to 2.5 105 cells were subjected to
electrophoresis in NuPAGE Novex 4–12% Bis-Tris precast gels
(Invitrogen). The procedures used for immunoblotting have been
described elsewhere [23].
Antibodies
All the commercial antibodies were used according to the
manufacturers’ specifications. The primary antibodies were used
for immunofluorescence (IF), immunoprecipitation (IP) or immu-
noblotting (IB) at the following concentrations: rabbit anti-BLM
(1:5000 for IB and 1:200 for IF, AB476 from Abcam), goat anti-
BLM (1:150 for IF, C18 from Santa-Cruz Biotechnology), CREST
serum (1:500 for IF, from Antibody Incorporated (Fig. 1), kindly
provided by I. Bahon-Riedinger (Fig. 2)), mouse anti-cyclin B1
(1:500 for IF, sc-245 from Santa Cruz), mouse anti-Rad21 (1:1000
for IB, 53A303 from Upstate), mouse anti-Topo II alpha (1:1000
BLM and PICH in Centromere Disjunction
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for IB and IF, 3D4 from Assay Design), mouse anti-Topo II alpha
(1:250 for IP, KiS1 from Millipore), anti-b-actin (1:10000 for IB;
Sigma), anti-GAPDH (1:10000 for IB; Millipore), anti-PICH
(1:200 for IF and 1:750 for IB, DO1P from Abnova) and anti-
CENP-A (1:200 for IF, AB13939 from Abcam). Secondary
antibodies conjugated to Alexa Fluor 488, 555 and 633 (Molecular
Probes, 1:200-600) were used for immunofluorescence and
secondary antibodies conjugated to horseradish peroxidase (Santa
Cruz, 1:5000-10000) were used for immunoblot detection.
Reverse Transcription and Real-time Quantitative PCR
Total RNA was extracted with the RNeasy Mini kit (Qiagen)
including a DNAse digestion step. cDNAs were synthesized with
250 ng of random hexamers (Invitrogen), 2 mg of RNA and
Superscript II reverse transcriptase (Invitrogen). qPCR experi-
Figure 5. PICH and BLM are required for the recruitment of Topo IIa to centromeres (A) ChIP-PCR analysis of Topo IIa recruitment to
pericentromeric region satellite 3 (Sat3) or to the centromeric DNA of chromosomes X (DXZ1) or 17 (D17Z1) was performed in GFP-
BLM and BS cells (lower panels). The histogram shows relative enrichment in DXZ1 (DXZ1/Sat3) or D17Z1 (D17Z1/Sat3) sequences for active
Topo IIa in GFP-BLM (defined as 1) and in BS cells (upper panels). The results presented are from three independent experiments. Error bars indicate
the SD. (B) We performed the same experiments as in (A), with GFP-BLM cells transfected for 72 hours with control siRNAs or PICH siRNAs. (C) The
amount of Topo II was evaluated in each cell line by western blotting. (D) We performed the same experiments as in (A), with GFP-BLM, GFP-I841T
and BS cells.
doi:10.1371/journal.pone.0033905.g005
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ments were performed according to the MIQE Guidelines [24].
Amplification mixtures contained the cDNA template (1/100
dilution), SYBR Green Supermix 16 (BioRad) and 300 nM
forward and reverse primers. Amplification was performed with
the CFX96 detection system (BioRad). The primer sequences for
Rad21 have been described on the website www.rtprimerdb.org
(RTPrimerDB ID:8036). The relative quantities of the Rad21
cDNAs were normalized against two reference genes (RPL32,
SDHA) chosen on the basis of their low M-value [25,26].
Immunofluorescence Microscopy
Immunofluorescence staining was performed as previously
described [27] with the inclusion of a prepermeabilization
incubation with 0.5% Triton X-100 before fixation for the
detection of chromatid-bound protein. Nuclear DNA was detected
by mounting slides in ProlongH Gold antifade reagent supple-
mented with DAPI (Invitrogen). Cell images were acquired with a
3-D deconvolution imaging system consisting of a Leica DM RXA
microscope equipped with a piezoelectric translator (PIFOC; PI)
placed at the base of a 63x PlanApo N.A. 1.4 objective, and a
CoolSNAP HQ interline CCD camera (Photometrics). Stacks of
conventional fluorescence images were collected automatically at a
Z-distance of 0.2 mm (Metamorph software; Molecular Devices).
Images are presented as maximum intensity projections generated
with ImageJ software, from stacks deconvolved with an extension
of Metamorph software [28].
FISH Analysis
FISH was performed with the CEP-8 probe (CEN-8) from
Abbott Vysis according to the manufacturer’s instructions with
fixation of cells in paraformaldehyde. Images were acquired on a
Leica SP5 confocal system, equipped with an argon laser, with
405 nm and 561 nm laser diodes, using a 636/1.4 objective. All
recordings were made with the appropriate sampling frequency
(5126512 images, line average of 8 and zooming set to 8, pixel
size: 60.2 nm). Image processing and quantification were carried
out with the freely available Image J software [29]. FISH signal
volume was determined with the 3D object counter plugin to
Image J software [30]. A binary 3D image was generated, and a
tagged map of all objects was obtained, based on pixel connexity
(one tag per independent FISH signal, 26-neighbor connexity).
The number of voxels (i.e. 3D pixels) carrying each tag was
retrieved, then multiplied by the unit volume of the voxel (64.5 nm
664.5 nm6200 nm), to obtain the volume of each object. More
information is available from the documentation supplied for the
plugin: (http://imagejdocu.tudor.lu/lib/exe/fetch.
php?media = plugin:analysis:3d_object_counter:3d-oc.pdf).
Chromosome Spreading and Immunolabeling
Cells were left untreated or were transfected as indicated. After
48 h of transfection with an siRNA specific for Rad21, cells were
transferred to slides in 6-well plates. After 24h at 37uC, colchicine
was added to a final concentration of 0.1 mg/ml and the cells were
incubated for 1 hour. The cells were then incubated in hypotonic
solution (1:5 (vol/vol) FCS-distilled water) and fixed by incubation
with a 3:1 (vol/vol) mixture of methanol and acetic acid. Cells
were then stained by incubation with 2% Giemsa solution (VWR)
for 16 minutes, rinsed in distilled water, dried, and mounted.
Chromosomes were observed with a Leica DMRB microscope at
1006 magnification. Metaphases were captured with a SONY
Figure 6. Model of PICH/BLM-dependent decatenation of centromeric DNA. We propose that the combined action of BLM and PICH
promotes the organization of centromeric chromatin, thereby rendering some centromeric catenates accessible to Topo IIa. In the absence of BLM or
PICH, a defect in the recruitment of active Topo IIa results in the persistence of some catenations leading to centromeric non disjunction and the
formation of additional UFBs.
doi:10.1371/journal.pone.0033905.g006
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DXC 930 P camera. Centromeric disjunction classification was
evaluated by retrieving intensity profiles with the ‘‘plot profile
function’’ of ImageJ applied to distance-calibrated images, along a
line placed over the primary constriction region. For chromosome
immunolabeling, chromosome spreads were obtained by cytocen-
trifugation and processed as previously described [27].
Topo II ChIP Analysis
Cells (106) were treated with 0.5 mM etoposide for 15 min.
They were then lysed in 1.5 ml of buffer containing 1% Sarkosyl,
10 mM Tris-HCl (pH 7.5), 10 mM EDTA, and protease inhibitor
mixture (Complete Mini, Roche) by 10 passages through a 21G
needle. CsCl was added from a concentrated stock solution (7 M),
to give a final concentration of 0.5 M. DNA was fragmented by
sonicating lysates with a Bioruptor sonicator (Diagenode), with 20-
second pulses (20 seconds on/20 seconds off), for 15 minutes at the
high-power setting. Under these conditions, DNA fragments of 0.5
to 3 kb were generated, as shown by agarose gel electrophoresis.
Before immunoprecipitation (IP), we added 3 volumes of a buffer
containing 10 mM Tris-HCl (pH 7.5), 10 mM EDTA, 100 mM
NaCl, 0.1% Triton X-100, and protease inhibitor mixture to 1
volume of lysate. The resulting mixture was then centrifuged for
15 min at 16 0006 g at 4uC. Preclearing was then achieved by
adding 60 ml of Protein G plus agarose beads (Santa Cruz) and
rotating the tubes for 2 h at 4uC. The unbound fraction recovered
by centrifugation was used for IP reactions. It was incubated
overnight, at 4uC, with gentle shaking, with 5 mg of specific anti-
Topo II antibody (KiS1) or control antibody (mouse IgG). Protein
G plus agarose beads (Santa Cruz) were added and the mixture
was incubated for 1 h. The beads were collected by centrifugation
and washed three times with 150 mM NaCl buffer (10 mM Tris-
HCl pH 7.5, 10 mM EDTA, 150 mM NaCl, 0.1% Triton X-100,
protease inhibitor). Three rounds of elution were then carried out
with 500 mM NaCl buffer (10 mM Tris-HCl pH 7.5, 10 mM
EDTA, 500 mM NaCl, 0.1% Triton X-100, protease inhibitor),
with the beads collected by centrifugation between elutions. The
DNA fragments bound to the beads were treated with 50 mg/ml
RNase A, at 55uC, for 30 min, then with 200 mg/ml proteinase K
at 55uC overnight. They were then purified with the MiniElute
PCR Purification kit (QIAGEN), according to the manufacturers’
instructions. DNA fragments were quantified with the Quant-IT
Pico Green dsDNA kit (InvitrogenTM, Molecular ProbesH),
according to the manufacturer’s protocol. Alpha-satellite DNA
(20 pg) from chromosome X or chromosome 17 (DXZ1 and
D17Z1, respectively) [31] or from pericentromeric DNA satellite 3
[32] was amplified by semiquantitative PCR. PCR products were
analyzed by agarose gel electrophoresis and quantified with Image
J (NIH) software. The signal obtained from the GFP-BLM cells
was taken as 1.
Electron Microscopy
BS and GFP-BLM cells grown at low density on coverslips were
fixed by incubation with 2% paraformaldehyde, 2.5% glutaralde-
hyde in 0.1 M cacodylate buffer for 24 h and postfixed by
incubation with 1% (wt/vol) OsO4 supplemented with 1.5% (wt/
vol) ferrocyanide. They were then dehydrated in ethanol and
embedded in Epon. Ultrathin sections were prepared with a
Reichert UltracutS ultramicrotome (Leica) and viewed with a
TEM CM120 Philips electron microscope after counterstaining
with uranyl acetate and lead citrate.
Statistical Methods
Significance was assessed with Student’s t-test. For all tests,
p,0.05 was considered statistically significant.
Supporting Information
Table S1 Sequences of the siRNAs used in this study.
(XLS)
Figure S1 GFP-BLM localizes to the PML body. Coloca-
lization of GFP-BLM (green) with PML (red). Nuclei were
visualized by DAPI staining (blue). Scale bar = 5 mm.
(TIF)
Figure S2 Kinetochore structure is not profoundly
affected in BLM-deficient cells. CENP-A immunostaining
of BS and GFP-BLM metaphase cells revealed a similar
localization in the two types of cells. Chromosomes are visualized
by DAPI staining (red). Scale bar = 5 mm. Similar results were
obtained with 5 representative kinetochore/centromere proteins
(AURORA B, CENP-I, HEC, BUB1 and BUBR1).
(TIF)
Figure S3 Structural defects at the centromeres in BLM-
and PICH-deficient HeLa cells. Comparison of the volume of
the centromeric FISH signal detected on chromosomes 8 from
HeLaV-siCtrl (defined as 1), HeLa V-siPICH, HeLash-siBLM and
HeLash-siBLM-siPICH cells (right panel). We analyzed between
18 and 27 metaphase cells from two independent experiments for
each cell line. BLM and PICH protein levels were assessed by
immunoblotting, probing the same membrane with anti-BLM (ab-
476) and anti-PICH antibodies and with anti-b actin antibody, as
a loading control (upper left panel).
(TIF)
Figure S4 BLM-downregulated and PICH-downregulat-
ed HeLa cells display non disjunction of centromeres.
HeLa cells were transfected for 72 hours with Rad21 siRNAs and
transfected with control siRNAs, BLM siRNAs or PICH siRNAs.
BLM, PICH and Rad21 protein levels were assessed by
immunoblotting, probing the same membrane with anti-BLM
(ab-476), anti-PICH and anti-Rad21 antibodies and with anti-b
actin antibody, as a loading control (left panel). Chromosome
spreads were performed and sorted on the basis of their
phenotype: X-shapes, incomplete disjunction or complete disjunc-
tion. We analyzed 500 spreads from two independent experiments
for each cell line. The frequency of each phenotype, in each of the
three cell lines, is shown in the histogram (right panel). Bars
represent SD.
(TIF)
Figure S5 siRNA-mediated Rad21 downregulation was
similarly effective in all conditions. GFP-BLM or HeLa
cells were transfected for 72 hours with the indicated siRNAs.
Rad21 mRNA levels were determined by reverse transcription
quantitative PCR in all conditions. Histograms represent the
amplification of Rad21 mRNA from one experiment in triplicate
for GFP-BLM and BS cells and are the mean of the amplification
of Rad21 mRNA in triplicate in two independent experiments for
HeLa cells. Bars represent s.e.m.
(TIF)
Figure S6 Centromeric UFBs are not detectable in
PICH-deficient cells. (A) (Upper panels) GFP-BLM cells were
transfected for 72 hours with PICH or control siRNAs. UFBs were
detected by immunostaining of BLM and PICH and quantified
(164 UFBs from 129 siCtrl cells and 21 UFBs from 129 siPICH
cells were scored in three independent experiments, respectively).
Bars represent SDs. (Lower panel) Representative example of a
UFB in anaphase cells revealed by BLM staining. The nucleus was
visualized by DAPI staining (blue). Scale bar = 5 mm. (B) Total
number of UFBs detected and scored in PICH-downregulated
BLM and PICH in Centromere Disjunction
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cells. UFBs positive for PICH only or for BLM only or for both
PICH and BLM were scored in three independent experiments
including a total of 129 cells transfected with control siRNAs and
129 cells transfected with PICH siRNAs.
(TIF)
Acknowledgments
We thank L. Aragon for invaluable discussions, A. Carreira, S. Lambert
and O. Gavet for helpful discussions and useful comments on the
manuscript, S. Augui and O. Philipot for advice concerning FISH and
ChIP and T. Verly for graphical support.
Author Contributions
Conceived and designed the experiments: SR MAG. Performed the
experiments: SR GBL IH ROD SG LMJ. Analyzed the data: SR FPC CJ
MAG. Wrote the paper: SR MAG.
References
1. Carroll CW, Straight AF (2006) Centromere formation: from epigenetics to self-
assembly. Trends Cell Biol 16: 70–78.
2. Cleveland DW, Mao Y, Sullivan KF (2003) Centromeres and kinetochores: from
epigenetics to mitotic checkpoint signaling. Cell 112: 407–421.
3. Yuen KW, Montpetit B, Hieter P (2005) The kinetochore and cancer: what’s the
connection? Curr Opin Cell Biol 17: 576–582.
4. Baumann C, Korner R, Hofmann K, Nigg EA (2007) PICH, a centromere-
associated SNF2 family ATPase, is regulated by Plk1 and required for the
spindle checkpoint. Cell 128: 101–114.
5. Chan KL, North PS, Hickson ID (2007) BLM is required for faithful
chromosome segregation and its localization defines a class of ultrafine anaphase
bridges. EMBO J 26: 3397–3409.
6. Wang LH, Schwarzbraun T, Speicher MR, Nigg EA (2008) Persistence of DNA
threads in human anaphase cells suggests late completion of sister chromatid
decatenation. Chromosoma 117: 123–135.
7. Wang LH, Mayer B, Stemmann O, Nigg EA (2010) Centromere DNA
decatenation depends on cohesin removal and is required for mammalian cell
division. J Cell Sci 123: 806–813.
8. Amor-Gueret M (2006) Bloom syndrome, genomic instability and cancer: the
SOS-like hypothesis. Cancer Lett 236: 1–12.
9. Ke Y, Huh JW, Warrington R, Li B, Wu N, et al. (2011) PICH and BLM limit
histone association with anaphase centromeric DNA threads and promote their
resolution. EMBO J 30: 3309–3321.
10. Chabosseau P, Buhagiar-Labarchede G, Onclercq-Delic R, Lambert S,
Debatisse M, et al. (2011) Pyrimidine pool imbalance induced by BLM helicase
deficiency contributes to genetic instability in Bloom syndrome. Nat Commun 2:
368.
11. Yankiwski V, Marciniak RA, Guarente L, Neff NF (2000) Nuclear structure in
normal and Bloom syndrome cells. Proc Natl Acad Sci U S A 97: 5214–5219.
12. Pines J, Hunter T (1991) Human cyclins A and B1 are differentially located in
the cell and undergo cell cycle-dependent nuclear transport. J Cell Biol 115:
1–17.
13. Guo RB, Rigolet P, Ren H, Zhang B, Zhang XD, et al. (2007) Structural and
functional analyses of disease-causing missense mutations in Bloom syndrome
protein. Nucleic Acids Res 35: 6297–6310.
14. Batram C, Baddeley D, Kreth G, Cremer C (2008) High precision size
measurement of centromere 8 and the 8q24/c-myc gene region in metaphase
and interphase human fibroblasts indicate differential condensation. J Struct Biol
164: 293–303.
15. Ke Y, Huh JW, Warrington R, Li B, Wu N, et al. (2011) PICH and BLM limit
histone association with anaphase centromeric DNA threads and promote their
resolution. EMBO J 30: 3309–3021.
16. Diaz-Martinez LA, Gimenez-Abian JF, Clarke DJ (2008) Chromosome cohesion
- rings, knots, orcs and fellowship. J Cell Sci 121: 2107–2114.
17. Chan KL, Hickson ID (2011) New insights into the formation and resolution of
ultra-fine anaphase bridges. Semin Cell Dev Biol 22: 906–912.
18. Sano K, Miyaji-Yamaguchi M, Tsutsui KM, Tsutsui K (2008) Topoisomerase
IIbeta activates a subset of neuronal genes that are repressed in AT-rich genomic
environment. PLoS One 3: e4103.
19. Baxter J, Sen N, Martinez VL, De Carandini ME, Schvartzman JB, et al. (2011)
Positive supercoiling of mitotic DNA drives decatenation by topoisomerase II in
eukaryotes. Science 331: 1328–1332.
20. Eladad S, Ye TZ, Hu P, Leversha M, Beresten S, et al. (2005) Intra-nuclear
trafficking of the BLM helicase to DNA damage-induced foci is regulated by
SUMO modification. Hum Mol Genet 14: 1351–1365.
21. Lahkim Bennani-Belhaj K, Rouzeau S, Buhagiar-Labarchede G, Chabosseau P,
Onclercq-Delic R, et al. (2010) The Bloom syndrome protein limits the lethality
associated with RAD51 deficiency. Mol Cancer Res 8: 385–394.
22. Hubner NC, Wang LH, Kaulich M, Descombes P, Poser I, et al. (2010) Re-
examination of siRNA specificity questions role of PICH and Tao1 in the
spindle checkpoint and identifies Mad2 as a sensitive target for small RNAs.
Chromosoma 119: 149–165.
23. Ababou M, Dumaire V, Lecluse Y, Amor-Gueret M (2002) Cleavage of BLM
and sensitivity of Bloom’s syndrome cells to hydroxurea and UV-C radiation.
Cell Cycle 1: 262–266.
24. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, et al. (2009) The MIQE
guidelines: minimum information for publication of quantitative real-time PCR
experiments. Clin Chem 55: 611–622.
25. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002)
Accurate normalization of real-time quantitative RT-PCR data by geometric
averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034.
26. Viegas MH, Gehring NH, Breit S, Hentze MW, Kulozik AE (2007) The
abundance of RNPS1, a protein component of the exon junction complex, can
determine the variability in efficiency of the Nonsense Mediated Decay pathway.
Nucleic Acids Res 35: 4542–4551.
27. Eot-Houllier G, Fulcrand G, Watanabe Y, Magnaghi-Jaulin L, Jaulin C (2008)
Histone deacetylase 3 is required for centromeric H3K4 deacetylation and sister
chromatid cohesion. Genes Dev 22: 2639–2644.
28. Savino TM, Gebrane-Younes J, De Mey J, Sibarita JB, Hernandez-Verdun D
(2001) Nucleolar assembly of the rRNA processing machinery in living cells.
J Cell Biol 153: 1097–1110.
29. Agostinho M, Rino J, Braga J, Ferreira F, Steffensen S, et al. (2004) Human
topoisomerase IIalpha: targeting to subchromosomal sites of activity during
interphase and mitosis. Mol Biol Cell 15: 2388–2400.
30. Bolte S, Cordelieres FP (2006) A guided tour into subcellular colocalization
analysis in light microscopy. J Microsc 224: 213–232.
31. Warburton PE, Greig GM, Haaf T, Willard HF (1991) PCR amplification of
chromosome-specific alpha satellite DNA: definition of centromeric STS
markers and polymorphic analysis. Genomics 11: 324–333.
32. Jolly C, Metz A, Govin J, Vigneron M, Turner BM, et al. (2004) Stress-induced
transcription of satellite III repeats. J Cell Biol 164: 25–33.
BLM and PICH in Centromere Disjunction
PLoS ONE | www.plosone.org 12 April 2012 | Volume 7 | Issue 4 | e33905
